Thermo Fisher Scientific (TMO) Earnings Analysis

Thermo Fisher Scientific (TMO) next reports earnings on 2026-10-28, consensus EPS 6.36 USD. Last quarter (2026-07-23) it beat with EPS 6.03 USD vs 5.72 USD est (+5.4%). It has beaten estimates in 7/7 recent quarters (100%). Trailing P/E 28.89.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does TMO next report earnings?

Next earnings date2026-10-28
Consensus EPS estimate6.36 USD
Revenue estimate11.96B

TMO earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-07-236.03 USD5.72 USD+5.4%Beat
2026-04-235.44 USD5.25 USD+3.6%Beat
2026-01-296.57 USD6.45 USD+1.9%Beat
2025-10-225.79 USD5.5 USD+5.3%Beat
2025-07-235.36 USD5.23 USD+2.5%Beat
2025-01-306.1 USD5.94 USD+2.7%Beat
2024-07-245.37 USD5.12 USD+4.9%Beat

Beat rate: 7/7 (100%) over reported quarters with consensus data.

TMO valuation and analyst view

Trailing P/E28.89
Trailing EPS18.438 USD
Price / book3.77
Dividend yield0.34%
Market cap194.65B
Analyst consensusBuy (37 buy / 5 hold / 0 sell)
Avg price target561.13 USD

Related research pages

Frequently asked questions

When is Thermo Fisher Scientific (TMO)'s next earnings date?

Thermo Fisher Scientific is next scheduled to report on 2026-10-28, with a consensus EPS estimate of 6.36 USD and revenue estimate of 11.96B.

Did TMO beat earnings last quarter?

In its 2026-07-23 report, TMO posted EPS of 6.03 USD versus a 5.72 USD estimate — a beat of 5.4%.

What is TMO's earnings track record?

Over the last 7 reported quarters with consensus data, TMO beat estimates 7 times (100%).

What is TMO's current P/E ratio and EPS?

TMO trades at a trailing P/E of 28.89 on trailing EPS of 18.438172043010752 USD.

What do analysts rate TMO?

Analyst consensus is "Buy" across 42 ratings (0 strong buy, 37 buy, 5 hold, 0 sell, 0 strong sell). Average 12-month price target: 561.13 USD.